Takaaki Ono

Hamamatsu, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 57 publications

ELTS Score and Early "Warning" Define a Two-Stage Risk Framework for Failure-Free Survival in Chronic-Phase CML.

ELTS Score and Early "Warning" Define a Two-Stage Risk Framework for Failure-Free Survival in Chronic-Phase CML.

Journal: Blood advances

Published: May 12, 2026

Treatment-Free Remission and Immune Profiling after Frontline Second-Generation TKI Therapy in CML.

Treatment-Free Remission and Immune Profiling after Frontline Second-Generation TKI Therapy in CML.

Journal: Blood advances

Published: May 05, 2026

Reattempt of tyrosine kinase inhibitor discontinuation after maintenance therapy with ponatinib in patients with chronic myeloid leukaemia in the chronic phase: Result of the Japan Adult Leukemia Study Group RE-STOP219 study.

Reattempt of tyrosine kinase inhibitor discontinuation after maintenance therapy with ponatinib in patients with chronic myeloid leukaemia in the chronic phase: Result of the Japan Adult Leukemia Study Group RE-STOP219 study.

Journal: British journal of haematology

Published: March 12, 2026

Key points in second-line therapy for chronic myeloid leukemia

Key points in second-line therapy for chronic myeloid leukemia

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: March 04, 2026

Long-term outcomes of low-dose dasatinib in older patients with chronic myeloid leukemia in chronic phase: an extended follow-up of the DAVLEC phase 2 trial.

Long-term outcomes of low-dose dasatinib in older patients with chronic myeloid leukemia in chronic phase: an extended follow-up of the DAVLEC phase 2 trial.

Journal: Blood cancer journal

Published: February 14, 2026

Early predictors of MR4.5 attainment and eligibility for TKI discontinuation in CML treated with second-generation TKIs.

Early predictors of MR4.5 attainment and eligibility for TKI discontinuation in CML treated with second-generation TKIs.

Journal: Blood advances

Published: January 13, 2026

Recombinant zoster vaccine induces superior immunogenicity compared with live varicella vaccine in allogeneic haematopoietic stem cell transplantation recipients.

Recombinant zoster vaccine induces superior immunogenicity compared with live varicella vaccine in allogeneic haematopoietic stem cell transplantation recipients.

Journal: British journal of haematology

Published: January 06, 2026

Five-year interim analysis of J-SKI: an observational study of TKI discontinuation in patients with CML in Japan.

Five-year interim analysis of J-SKI: an observational study of TKI discontinuation in patients with CML in Japan.

Journal: International journal of hematology

Published: December 03, 2025

Predicting intraoperative transfusion volumes of blood products in cardiovascular surgery: a retrospective study.

Predicting intraoperative transfusion volumes of blood products in cardiovascular surgery: a retrospective study.

Journal: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis

Published: September 29, 2025

Serum presepsin level reflects macrophage activation and hemophagocytosis in bone marrow.

Serum presepsin level reflects macrophage activation and hemophagocytosis in bone marrow.

Journal: PloS one

Published: August 28, 2025

Long-term immunity to measles and rubella after vaccination in adult allogeneic hematopoietic stem cell transplant recipients.

Long-term immunity to measles and rubella after vaccination in adult allogeneic hematopoietic stem cell transplant recipients.

Journal: International journal of hematology

Published: March 17, 2025

Bosutinib for Successful Treatment-Free Remission in Chronic Myeloid Leukemia.

Bosutinib for Successful Treatment-Free Remission in Chronic Myeloid Leukemia.

Journal: Cancer medicine

Published: December 05, 2024

Showing 1-12 of 57

Last Updated: 09/26/2026